|
New York, NY, November 19, 2009-Ebitda News reports that negative EBITDA for Nabi Biopharmaceuticals (NASDAQ:NABI) for its quarter ended September 30, 2009 was $(6,790,000), a 29% deterioration over t ... read full story |
|
| Website Address: |
www.nabi.com |
| Industry: |
Vaccine, Antibodies, Immunities
|
|